Dr. Mark Seligman is Chief Linguist at Speech Morphing, Inc., a vendor of text-to-speech and speech translation services. In 1998, he organized the first speech translation system demonstrating broad coverage with acceptable quality. In 2002, he founded Spoken Translation, Inc. The company’s speech translation product for healthcare was successfully pilot tested at Kaiser Permanente’s Medical Center in San Francisco. Mark serves on the Advisory Board of TAUS (the Translation Automation Users Society) and on the Steering Committee of IWSLT (the International Workshop for Spoken Language Translation). He also publishes on speech translation and cognitive science topics.
